On day 28, the ROP risk was reduced when the neurotropic factors NT-4 and/or BDNF were in the top quartile, but this risk reduction was observed only when the three inflammation-related proteins, IL-6, TNF-α, and ICAM-1, were in the lower three quartiles. The gene discussed is BDNF; the disease is retinopathy of prematurity.